2017 Annual General Meeting of Shareholders (28th February 2017)


2017 Annual General Meeting of Shareholders
(28th February 2017)

February 8, 2017

Dear All,

The proxy advisor, Institutional Shareholder Services (ISS), issued their report on Novartis in advance of the Novartis
Annual General Meeting.

For your information, please find attached to this email (also on the following link
https://www.novartis.com/investors/shareholder-information/annual-general-meeting), the response to the ISS report
from Mr. Enrico Vanni, Chairman of the Compensation Committee, Novartis.

If you have any questions or require clarification please do not hesitate to contact the Investor Relations team.

Thank you and kind regards

Novartis International AG
Investor Relations

Basel Office  
General Phone +41 61 324 79 44
Samir Shah +41 61 324 79 44
Pierre-Michel Bringer +41 61 324 10 65
Thomas Hungerbuehler +41 61 324 84 25
Isabella Zinck +41 61 324 71 88
North America Office  
Richard Pulik +1 212 830 24 48
Sloan Pavsner +1 212 830 24 17
Email: investor.relations@novartis.com
www.novartis.com

Title: Novartis

   
   
   
   
   
   
   
   
   
 

Attachments

Response to the ISS report